Keyur Patel

16.4k total citations · 5 hit papers
175 papers, 8.5k citations indexed

About

Keyur Patel is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Keyur Patel has authored 175 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Hepatology, 128 papers in Epidemiology and 13 papers in Surgery. Recurrent topics in Keyur Patel's work include Liver Disease Diagnosis and Treatment (116 papers), Hepatitis C virus research (95 papers) and Hepatitis B Virus Studies (51 papers). Keyur Patel is often cited by papers focused on Liver Disease Diagnosis and Treatment (116 papers), Hepatitis C virus research (95 papers) and Hepatitis B Virus Studies (51 papers). Keyur Patel collaborates with scholars based in United States, Canada and United Kingdom. Keyur Patel's co-authors include John G. McHutchison, Eric Lawitz, Harry L.A. Janssen, M. Rodríguez‐Torres, Stefan Zeuzem, Giada Sebastiani, Michael R. Hodges, Sakari Kauppinen, Hendrik W. Reesink and Alice P. Chen and has published in prestigious journals such as New England Journal of Medicine, Blood and Gastroenterology.

In The Last Decade

Keyur Patel

171 papers receiving 8.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of HCV Infection by Targeting MicroRNA

2013 1.7k citations Harry L.A. Janssen, Keyur Patel et al. profile →
Adherence to combination therapy enhances sustained response in genotype-1–infected patients with chronic hepatitis C

2002 775 citations John G. McHutchison, Keyur Patel et al. profile →
Limitations of non-invasive tests for assessment of liver fibrosis

2020 199 citations Keyur Patel, Giada Sebastiani JHEP Reports profile →
AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis

2024 63 citations Richard K. Sterling, Andrés Duarte‐Rojo et al. Hepatology profile →
AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis

2024 44 citations Richard K. Sterling, Keyur Patel et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keyur Patel United States	47	5.3k	5.2k	1.8k	1.3k	566	175	8.5k
Ming‐Lung Yu Taiwan	53	7.4k 1.4×	7.7k 1.5×	1.1k 0.6×	541 0.4×	744 1.3×	490	10.8k
Hwai‐I Yang Taiwan	48	7.5k 1.4×	8.5k 1.6×	1.1k 0.6×	671 0.5×	467 0.8×	178	10.9k
Wan‐Long Chuang Taiwan	53	8.5k 1.6×	8.3k 1.6×	939 0.5×	475 0.4×	732 1.3×	513	11.1k
Chia‐Yen Dai Taiwan	42	4.5k 0.9×	4.6k 0.9×	764 0.4×	450 0.3×	332 0.6×	354	6.5k
Françoise Degos France	42	6.5k 1.2×	6.7k 1.3×	1.2k 0.7×	641 0.5×	729 1.3×	145	9.1k
Hidenori Toyoda Japan	53	8.6k 1.6×	7.5k 1.4×	2.3k 1.3×	2.5k 1.9×	1.7k 3.0×	386	12.6k
Yasuji Arase Japan	52	9.1k 1.7×	8.7k 1.7×	878 0.5×	497 0.4×	726 1.3×	394	11.6k
Takashi Kumada Japan	54	8.6k 1.6×	6.9k 1.3×	1.4k 0.8×	1.7k 1.3×	2.0k 3.6×	399	11.7k
Tetsuya Hosaka Japan	47	7.3k 1.4×	7.3k 1.4×	585 0.3×	378 0.3×	543 1.0×	324	9.0k
Namiki Izumi Japan	58	11.1k 2.1×	8.3k 1.6×	1.1k 0.6×	1.1k 0.8×	2.0k 3.6×	366	13.8k

Countries citing papers authored by Keyur Patel

Since Specialization

Citations

This map shows the geographic impact of Keyur Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keyur Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keyur Patel more than expected).

Fields of papers citing papers by Keyur Patel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keyur Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keyur Patel. The network helps show where Keyur Patel may publish in the future.

Co-authorship network of co-authors of Keyur Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Keyur Patel. A scholar is included among the top collaborators of Keyur Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keyur Patel. Keyur Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wegermann, Kara, Chia‐Yu Chu, Nhu Thao Nguyen Galván, et al.. (2025). Beyond the HIV Organ Policy Equity Act: Roadmap to expanding kidney and liver transplants for people with human immunodeficiency virus utilizing grafts from donors with human immunodeficiency virus. American Journal of Transplantation. 25(10). 2057–2066. 1 indexed citations

Doshi, Jimit, et al.. (2025). Genomic medicine and personalized treatment: a narrative review. Annals of Medicine and Surgery. 87(3). 1406–1414. 2 indexed citations

Romano, Jacob, Giada Sebastiani, Alnoor Ramji, et al.. (2024). Examining the prevalence of hepatic steatosis and advanced fibrosis using non-invasive measures across Canada: A national estimate using the Canadian Health Measures Survey (CHMS) from 2009-2019. Annals of Hepatology. 30(1). 101757–101757. 2 indexed citations

Chen, Qing, et al.. (2024). FRI-293 Association between liver fibrosis, mental health, and lifestyle behaviors in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease. Journal of Hepatology. 80. S497–S497.

Rockey, Don C., Mouaz Alsawas, Andrés Duarte‐Rojo, et al.. (2024). Noninvasive liver disease assessment to identify portal hypertension: Systematic and narrative reviews supporting the AASLD Practice Guideline. Hepatology. 81(3). 1086–1104. 11 indexed citations

Manon‐Jensen, Tina, Shu Sun, Ida Falk Villesen, et al.. (2022). An MMP‐degraded and cross‐linked fragment of type III collagen as a non‐invasive biomarker of hepatic fibrosis resolution. Liver International. 42(7). 1605–1617. 16 indexed citations

Terrault, Norah A., Anna S. Lok, Abdus S. Wahed, et al.. (2022). Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B. The American Journal of Gastroenterology. 118(7). 1214–1225. 11 indexed citations

Kleef, Laurens A. van, Hannah Choi, Willem Pieter Brouwer, et al.. (2021). Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B. JHEP Reports. 3(5). 100350–100350. 74 indexed citations

Patel, Keyur, Ryan Lamm, Peter J. Altshuler, Hien Dang, & Ashesh P. Shah. (2020). Hepatocellular Carcinoma—The Influence of Immunoanatomy and the Role of Immunotherapy. International Journal of Molecular Sciences. 21(18). 6757–6757. 14 indexed citations

10.

Karsdal, M.A., Sara Toftegaard Hjuler, Yi Luo, et al.. (2018). Assessment of liver fibrosis progression and regression by a serological collagen turnover profile. American Journal of Physiology-Gastrointestinal and Liver Physiology. 316(1). G25–G31. 42 indexed citations

11.

Younossi, Zobair M., Maria Stepanova, Tarik Asselah, et al.. (2017). Hepatitis C in Patients With Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes. Clinical Infectious Diseases. 66(11). 1742–1750. 18 indexed citations

12.

Tahhan, Ayman Samman, Salim S. Hayek, Pratik B. Sandesara, et al.. (2017). Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes. Atherosclerosis. 264. 108–114. 23 indexed citations

13.

Shepherd, Charles, Matthias J. Koepp, Keyur Patel, et al.. (2017). Understanding the health economic burden of patients with tuberous sclerosis complex (TSC) with epilepsy: a retrospective cohort study in the UK Clinical Practice Research Datalink (CPRD). BMJ Open. 7(10). e015236–e015236. 11 indexed citations

14.

Bédossa, Pierre, Keyur Patel, & Laurent Castéra. (2015). Histologic and noninvasive estimates of liver fibrosis. Clinical Liver Disease. 6(1). 5–8. 15 indexed citations

15.

Naggie, Susanna, Anu Osinusi, Antonios Katsounas, et al.. (2012). Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B -unfavorable genotype patients: Impaired viral kinetics and therapeutic response. Hepatology. 56(2). 444–454. 55 indexed citations

16.

Cyr, Derek D., Joseph E. Lucas, J. Will Thompson, et al.. (2011). Characterization of Serum Proteins Associated with IL28B Genotype among Patients with Chronic Hepatitis C. PLoS ONE. 6(7). e21854–e21854. 22 indexed citations

17.

Guha, Indra Neil, Robert P. Myers, Keyur Patel, & Jayant A. Talwalkar. (2011). Biomarkers of liver fibrosis: What lies beneath the receiver operating characteristic curve?. Hepatology. 54(4). 1454–1462. 47 indexed citations

18.

Lim, Rebecca, Belinda Knight, Keyur Patel, et al.. (2006). Antiproliferative effects of interferon alpha on hepatic progenitor cells in vitro and in vivo. Hepatology. 43(5). 1074–1083. 41 indexed citations

19.

Monto, Alexander, Keyur Patel, Alan Bostrom, et al.. (2004). Risks of a range of alcohol intake on hepatitis C-related fibrosis. Hepatology. 39(3). 826–834. 126 indexed citations

20.

Pianko, Stephen, John G. McHutchison, Stuart C. Gordon, et al.. (2002). Hepatic Iron Concentration Does Not Influence Response to Therapy with Interferon Plus Ribavirin in Chronic HCV Infection. Journal of Interferon & Cytokine Research. 22(4). 483–489. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact